1. Arai, M., Kashihara, K., & Kaizaki, Y. (2006). Enhancing gliotic cyst wall with microvascular proliferation adjacent to a meningioma. Journal of Clinical Neuroscience, 13(1), 136-9. [DOI:10.1016/j.jocn.2005.02.015] [PMID] [
DOI:10.1016/j.jocn.2005.02.015]
2. Buetow, M. P., Buetow, P. C., Smirniotopoulos, J. G. (1991). Typical, atypical, and misleading features in meningioma. Radiographics, 11(6), 1087-106. [DOI:10.1148/radiographics.11.6.1749851] [PMID] [
DOI:10.1148/radiographics.11.6.1749851]
3. Carvalho, L. H., Smirnov, I., Baia, G. S., Modrusan, Z., Smith, J. S., Jun, P., et al. (2007). Molecular signatures define two main classes of meningiomas. Molecular Cancer, 15(6), 64. [DOI:10.1186/1476-4598-6-64] [
DOI:10.1186/1476-4598-6-64]
4. Demir, M. K., Iplikcioglu, A. C., Dincer, A., Arslan, M., & Sav, A. (2006). Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. European Journal of Radiology, 60(1), 48-55. [DOI:10.1016/j.ejrad.2006.06.002] [PMID] [
DOI:10.1016/j.ejrad.2006.06.002]
5. Eberlin, L. S., Norton, I., Orringer, D., Dunn, I. F., Liu, X., Ide, J. L., et al. (2013). Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proceedings of the National Academy of Sciences of the United States of America, 110(5), 1611-6. [DOI:10.1073/pnas.1215687110] [PMID] [PMCID] [
DOI:10.1073/pnas.1215687110]
6. Filippi, C. G., Edgar, M. A., Ulug, A. M., Prowda, J. C., Heier, L. A., & Zimmerman, R. D. (2001). Appearance of meningiomas on diffusion-weighted images: Correlating diffusion constants with histopathologic findings. American Journal of Neuroradiology, 22(1), 65-72. [PMID] [
PMID]
7. Gangadhar, K., Santhosh, D., & Fatterpekar, G. M. (2013). Imaging features of intracranial meningiomas with histopathological correlation: A relook into old disease. Nepalese Journal of Radiology, 3(1), 14-32. [DOI:10.3126/njr.v3i1.8713] [
DOI:10.3126/njr.v3i1.8713]
8. Gao, X., Zhang, X. N., Zhang, Y. T., Yu, C. S., & Xu, D. S. (2011). Magnetic resonance imaging in assessment of treatment response of gamma knife for brain tumors. Chinese Medical Journal, 124(12), 1906-10.
9. Hakyemez, B., Yildirim, N., Erdogan, C., Kocaeli, H., Korfali, E., & Parlak, M. (2006). Meningiomas with conventional MRI findings resembling intraaxialtumors: Can perfusion-weighted MRI be helpful in differentiation? Neuroradiology, 48(10), 695-702. [DOI:10.1007/s00234-006-0115-y] [PMID] [
DOI:10.1007/s00234-006-0115-y]
10. Harting, I., Hartmann, M., Bonsanto, M. M., Sommer, C., & Sartor, K. (2004). Characterization of necrotic meningioma using diffusion MRI, perfusion MRI, and MR spectroscopy: Case report and review of the literature. Neuroradiology, 46(3), 189-93. [DOI:10.1007/s00234-003-1144-4] [PMID] [
DOI:10.1007/s00234-003-1144-4]
11. Ignjatovic, J., Stojanov, D., Stojanovic, N., Stefanovic, I., Benedeto Stojanov, D., Petrovic, S., et al. (2014). ADC is not reliable in determinating subtypes of meningiomas. Central European Journal of Medicine, 9(6), 773-7. [DOI:10.2478/s11536-013-0315-x] [
DOI:10.2478/s11536-013-0315-x]
12. Iwado, E., Ichikawa, T., Kosaka, H., Otsuka, S, Kambara, H., Tamiya, T., et al. (2012). Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas. Neuropathology, 32(6), 638-46 [DOI:10.1111/j.1440-1789.2012.01312.x] [PMID] [
DOI:10.1111/j.1440-1789.2012.01312.x]
13. Jensen, R., & Lee, J. (2012). Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery, 71(1), 146-56. [DOI:10.1227/NEU.0b013e3182567886] [PMID] [
DOI:10.1227/NEU.0b013e3182567886]
14. Jensen, R. L., Mumert, M. L., Gillespie, D. L., Kinney, A. Y., Schabel, M. C., & Salzman, K. L. (2014). Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro-Oncology, 16(2), 280-91. [DOI:10.1093/neuonc/not148] [PMID] [PMCID] [
DOI:10.1093/neuonc/not148]
15. Jensen, R. L., Soleau, S., Bhayani, M. K., & Christiansen, D. (2002). Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. Journal of Neurosurgery, 97(3), 658-67. [DOI:10.3171/jns.2002.97.3.0658] [
DOI:10.3171/jns.2002.97.3.0658]
16. Kaynar, M. Y., Sanus, G. Z., Hnimoglu, H., Kacira, T., Kemerdere, R., Atukeren, P., et al. (2008). Expression of hypoxia inducible factor-1alpha in tumors of patients with glioblastoma multiforme and transitional meningioma. Journal of Clinical Neuroscience, 15(9), 1036-42. [DOI:10.1016/j.jocn.2007.07.080] [PMID] [
DOI:10.1016/j.jocn.2007.07.080]
17. Kircher, M.F., de la Zerda, A., Jokerst, J. V., Zavaleta, C. L., Kempen, P. J., Mittra, E., et al. (2012). A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nature Medicine, 18(5), 829-34. [DOI:10.1038/nm.2721] [PMID] [PMCID] [
DOI:10.1038/nm.2721]
18. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., et al. (2007). The 2007 WHO classification of tumors of the central nervous system. ActaNeuropathol, 114(2), 97-109. [DOI:10.1007/s00401-007-0243-4] [PMID] [PMCID] [
DOI:10.1007/s00401-007-0243-4]
19. Moffat, B. A., Chenevert, T. L., Meyer, C. R., Mckeever, P. E., Hall, D. E., Hoff, B. A., et al. (2006). The functional diffusion map: An imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia, 8(4), 259-67. [DOI:10.1593/neo.05844] [PMID] [PMCID] [
DOI:10.1593/neo.05844]
20. Monleón, D., Morales, J. M., Gonzalez Segura, A., Gonzalez Darder, J. M., Gil Benso, R., Cerdá Nicolás, M., et al. (2010). Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Research, 70(21), 8426-34. [DOI:10.1158/0008-5472.CAN-10-1498] [PMID] [
DOI:10.1158/0008-5472.CAN-10-1498]
21. Nagar, V. A., Ye, J. R., Ng, W. H., Chan, Y. H., Hui, F., Lee, C. K., et al. (2008). Diffusion-weighted mr imaging: Diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. American Journal of Neuroradiology, 29(6), 1147-52. [DOI:10.3174/ajnr.A0996] [PMID] [
DOI:10.3174/ajnr.A0996]
22. Qi, Z. G., Li, Y. X., Wang, Y., Geng, D. Y., Li, K. C., Shen, T. Z., et al. (2008). Lipid signal in evaluation of intracranial meningiomas. Chinese Medical Journal, 121(23), 2415-9.
23. Reszec, J., Hermanowicz, A., Rutkowski, R., Turek, G., Mariak, Z., Chyczewski, L. (2015). Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. BioMed Research International, 2015, 646853. [DOI:10.1155/2015/646853] [PMID] [PMCID] [
DOI:10.1155/2015/646853]
24. Russell, DS., Rubinstein, U. (1989). Pathology of tumors of the nervous system. Baltimore: Williams & Wilkins. [PMID]
25. Santelli, L., Ramondo, G., Della Puppa, A., Ermani, M., Scienza, R., d'Avella, D., et al. (2010). Diffusion-weighted imaging does not predict histological grading in meningiomas. Acta Neurochirurgica, 152(8), 1315-9. [DOI:10.1007/s00701-010-0657-y] [PMID] [
DOI:10.1007/s00701-010-0657-y]
26. Sanverdi, S. E., Ozgen, B., Oguz, K. K., Mut, M., Dolgun, A., Soylemezoglu, F., et al. (2012). Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas? European Journal of Radiology, 81(9), 2389-95. [DOI:10.1016/j.ejrad.2011.06.031] [PMID] [
DOI:10.1016/j.ejrad.2011.06.031]
27. Sharma, S., Ray, S., Moiyadi, A., Sridhar, E., & Srivastava, S. (2014). Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers. Scientific Reports, 4, 7140. [DOI:10.1038/srep07140] [PMID] [PMCID] [
DOI:10.1038/srep07140]
28. Stadnik, T. W., Chaskis, C., Michotte, A., Shabana, W. M., van Rompaey, K., Luypaert, R., et al. (2001). Diffusion-weighted MR imaging of intracerebral masses: Comparison with conventional MR imaging and histologic findings. American Journal of Neuroradiology, 22(5), 969-76. [PMID] [
PMID]
29. Taghva, A., Khalessi, A. A., Kim, P. E., Liu, C. Y., & Apuzzo, M. L. (2010). From atom to brain: Applications of molecular imaging to neurosurgery. World Neurosurgery, 73(5), 477-85. [DOI:10.1016/j.wneu.2010.02.058] [PMID] [
DOI:10.1016/j.wneu.2010.02.058]
30. Toh, C. H., Wei, K. C., Chang, C. N., Peng, Y. W., Ng, S. H., Wong, H. F., et al. (2014). Assessment of angiographic vascularity of meningiomas with dynamic susceptibility contrast-enhanced perfusion-weighted imaging and diffusion tensor imaging. American Journal of Neuroradiology, 35(2), 263-9. [DOI:10.3174/ajnr.A3651] [PMID] [
DOI:10.3174/ajnr.A3651]
31. Watson, M. A., Gutmann, D. H., Peterson, K., Chicoine, M. R., Kleinschmidt DeMasters, B. K., Brown, H. G., et al. (2002). Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. The American Journal of Pathology, 161(2), 665-72. [DOI:10.1016/S0002-9440(10)64222-8] [
DOI:10.1016/S0002-9440(10)64222-8]
32. Yin, B., Liu, L., Zhang, B. Y., Li, Y. X., Li, Y., & Geng, D. Y. (2012). Correlating apparent diffusion coefficients with histopathologic findings on meningiomas. European Journal of Radiology, 81(12), 4050-6. [DOI:10.1016/j.ejrad.2012.06.002] [PMID] [
DOI:10.1016/j.ejrad.2012.06.002]
33. Young, G. S. (2007). Advanced MRI of adult brain tumors. Neurologic clinics, 25(4), 947-73. [DOI:10.1016/j.ncl.2007.07.010] [PMID] [
DOI:10.1016/j.ncl.2007.07.010]
34. Zhang, H., Rödiger, L. A., Shen, T., Miao, J., & Oudkerk, M. (2008). Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology, 50(6), 525-30. [DOI:10.1007/s00234-008-0373-y] [PMID] [PMCID] [
DOI:10.1007/s00234-008-0373-y]
35. Zhu, F., Zhou, Y., Wang, C., Gao, J., & Qi, J. (2002). Perfusion MRI evaluation of correlating perfusion constants with histologic findings in meningiomas. Paper presented at International Society for Magnetic Resonance in Medicine. Berkeley, California, USA, 11-17 May 2019.